# Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis

> **NCT01578278** · PHASE2 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 606 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Bepotastine besilate formulation
- **DRUG:** Fluticasone propionate
- **DRUG:** Bepotastine besilate-fluticasone propionate
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01578278
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 606 (ACTUAL)
- **Last updated:** 2020-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01578278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01578278, "Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01578278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*